SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (57)3/3/1998 10:50:00 AM
From: scaram(o)ucheRead Replies (1) | Respond to of 4974
 
George:

VRII.... the purchasing was ongoing into the story unfolding in Peru, wasn't it? Acquisition in the face of justifiable weakness?

The MCDE royalties are single digit. Assume that Daiichi is 6%, and you'll be very close if not dead-on. Sure Lampert can get info relating to royalty levels. It's in a company's interest to help certain analysts, to prevent the analysts from making fools of themselves. So, you find a good (competent!) analyst or consultant that is a friend of the company, and you find the approximate royalty rate. I'm certain that Lampert and his advisors get some direct guidance.

How this thread is supposed to work? I'd like us to crawl inside the skin of those who move money through the industry, to understand who makes money and how. Lampert seems to focus on the long-term interest of patients, on excellence in science. Paramount/Aries/Rosenwald seem to focus, IMO, on the preservation of capital and the potential to bump into big money. They bumped into it with Interneuron, but, as we know, that story came apart at the seams.

The convergence of Lampert and Aries on RGEN is going to be fun to watch.

Here's fun news, moving money.......
biz.yahoo.com

I usually avoid Rosenwald-type companies like the plague. However, I've recently invested in two of them. Can anybody guess which two?

Cheers! Rick



To: aknahow who wrote (57)3/3/1998 11:28:00 AM
From: scaram(o)ucheRespond to of 4974
 
Remember, DNX is now Chrysalis and ARRS is AXPH.

Disclaimer.... I own a piece of four of these.

The search that George provided the link for.....

Company name Form Type Date Filed File Size

ADVANCED MAGNETICS INC SC 13D/A (12/24/1997) 25255 Bytes
ADVANCED MAGNETICS INC SC 13D/A (05/16/1997) 21350 Bytes
ADVANCED MAGNETICS INC SC 13D (10/30/1996) 25325 Bytes
ARRIS PHARMACEUTICAL CORP/DE/ SC 13D/A (12/08/1997) 30517 Bytes
ARRIS PHARMACEUTICAL CORP/DE/ SC 13D (10/03/1997) 29797 Bytes
CELLEGY PHARMACEUTICALS INC SC 13D (08/29/1997) 24512 Bytes
CHRYSALIS INTERNATIONAL CORP SC 13D/A (10/03/1997) 25449 Bytes
CORTECH INC SC 13D (05/16/1997) 35080 Bytes
CORVAS INTERNATIONAL INC SC 13D/A (11/07/1997) 22074 Bytes
CORVAS INTERNATIONAL INC SC 13D (05/16/1997) 35868 Bytes
DNX CORP SC 13D/A (11/19/1996) 23249 Bytes
GENOME THERAPEUTICS CORP SC 13D/A (03/04/1996) 26133 Bytes
MICROCIDE PHARMACEUTICALS INC SC 13D/A (02/27/1998) 22623 Bytes
MICROCIDE PHARMACEUTICALS INC SC 13D/A (11/10/1997) 28281 Bytes
MICROCIDE PHARMACEUTICALS INC SC 13D (08/29/1997) 30654 Bytes
NEUROGEN CORP SC 13D/A (12/24/1997) 24581 Bytes
NEUROGEN CORP SC 13D/A (08/29/1997) 23396 Bytes
NEUROGEN CORP SC 13D/A (05/05/1997) 30027 Bytes
NEUROGEN CORP SC 13D (03/18/1997) 29166 Bytes
NPS PHARMACEUTICALS INC SC 13D/A (02/27/1998) 23268 Bytes
NPS PHARMACEUTICALS INC SC 13D/A (12/24/1997) 26603 Bytes
NPS PHARMACEUTICALS INC SC 13D (05/16/1997) 29843 Bytes
SIBIA NEUROSCIENCES INC SC 13D (08/06/1997) 25661 Bytes
SYNAPTIC PHARMACEUTICAL CORP SC 13D/A (02/27/1998) 22257 Bytes
SYNAPTIC PHARMACEUTICAL CORP SC 13D/A (07/25/1997) 24610 Bytes
SYNAPTIC PHARMACEUTICAL CORP SC 13D (04/22/1997) 35881 Bytes
TRIPOS INC SC 13D (07/23/1997) 29339 Bytes
VIRUS RESEARCH INSTITUTE INC SC 13D (12/24/1997) 26376 Bytes